Venlafaxine
- Product NDC
- 70710-1352
- 11-digit product format
- 707101352
- Labeler code
- 70710
- Product ID
- 70710-1352_479c565e-3c2f-42a1-8a19-b7a210e5f28d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Venlafaxine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA215622
- Marketing category
- ANDA
- Marketing start
- 2022-09-01
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 225 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 7D7RX5A8MO | VENLAFAXINE HYDROCHLORIDE | 99300-78-4 | VENLAFAXINE HYDROCHLORIDE |
| GRZ5RCB1QG | VENLAFAXINE | 93413-69-5 | Venlafaxine |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 70710-1352-1 | 70710135201 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1352-1) | 2022-09-01 | No | No | Historical |
| 70710-1352-3 | 70710135203 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1352-3) | 2022-09-01 | No | No | Historical |
| 70710-1352-9 | 70710135209 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1352-9) | 2022-09-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Venlafaxine | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2023-09-01 | HUMAN PRESCRIPTION DRUG LABEL | 2 |